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Background: In contrast with human T-cell leukemia virus type 1 (HTLV-1) that causes ATL (adult T-cell leukemia),
HTLV-2 has not been causally linked to malignant disease. The minus strand of the HTLV genomes encode the
regulatory proteins HTLV-1 bZIP factor (HBZ) for HTLV-1 and antisense protein of HTLV-2 (APH-2) for HTLV-2. Unlike
the viral proteins Tax1 and Tax2, both HBZ and APH-2 are constitutively expressed in infected cells suggesting that
they may play important roles in the pathogenesis of these viruses. To date, very little is known about the function
of APH-2 except that it inhibits Tax2-mediated transcription of HTLV-2 genes. In the present study, we investigated
the role of APH-2 in basal and Tax2B-mediated activation of the AP-1 pathway.
Results: We demonstrate that, unlike HBZ, APH-2 stimulates basal AP-1 transcription by interacting with c-Jun and
JunB through its non-conventional bZIP domain. In addition, when Tax2 and APH-2 are co-expressed, they
physically interact in vivo and in vitro and APH-2 acts as an inhibitor of Tax2-mediated activation of AP-1
transcription.
Conclusions: This report is the first to document that HTLV-2 can modulate the AP-1 pathway. Altogether our
results reveal that, in contrast with HBZ, APH-2 regulates AP-1 activity in a Tax2-dependant manner. As the AP-1
pathway is involved in numerous cellular functions susceptible to affect the life cycle of the virus, these distinct
biological properties between HBZ and APH-2 may contribute to the differential pathogenic potential of HTLV-1
and HTLV-2.
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Thirty years after the discovery of the first human onco-
genic virus, the human T-cell leukemia virus (HTLV)
family of retroviruses is now composed of four members:
the well documented HTLV-1 and HTLV-2 and the re-
cently discovered HTLV-3 and HTLV-4 [1-4]. HTLV-1 is
the etiological agent of multiple disorders including
adult T-cell leukemia (ATL) and HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP)
[5,6]. The role of HTLV-2 in human disease is less
clearly defined but infection is associated with lympho-
cyte proliferation and high platelet counts as well as
milder neurological disorders [7-9]. However, while not
being associated with ATL like disorders, HTLV-2 is still* Correspondence: cmarban@unistra.fr
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reproduction in any medium, provided the orable to efficiently induce transformation of primary T-
cells [10].
In addition to the structural and enzymatic proteins
common to all retroviruses, HTLV-1 also encodes regu-
latory proteins such as Tax1. The HTLV-1 Tax protein is
a transcriptional activator that regulates HTLV-1 gene
expression but also modulates the expression of numer-
ous cellular genes through activation of cellular tran-
scription factors including NF-κB [11], CREB [12-16],
SRF [17] and AP-1 [18]. Activation of these major cellu-
lar signal transduction pathways plays a critical role in
T-cell transformation, and therefore ATL development.
Previous reports indicate that AP-1 activity is induced in
ATL cells [18,19]. Moreover, HTLV-1 Tax up-regulates
the transcription of several AP-1 family members such
as c-Jun, JunD, c-Fos and Fra-1 [20,21].
AP-1 consists of a myriad of homo- or hetero- dimers
that belong to the Jun, Fos, Maf and ATF subfamilies.
All AP-1 family members harbour a basic leucine zipperl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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rich in basic amino acids adjacent to a leucine zipper
structure required for protein-protein dimerization [22].
AP-1 dimers recognize either TPA response elements
(TRE) or cAMP response elements (CRE) which are
present in the promoter region of many cellular genes
involved in a large spectrum of biological processes in-
cluding cell proliferation, apoptosis and oncogenic trans-
formation [23].
Transcription from the 3’ Long Terminal Repeat (LTR)
of the HTLV genomes governs the expression of anti-
sense regulatory proteins named HTLV-1 bZIP factor
(HBZ) for HTLV-1 [24], antisense protein of HTLV-2
(APH-2) for HTLV-2 [25], APH-3 and APH-4 for
HTLV-3 and HTLV-4, respectively [26]. The HBZ gene
has been described as a key player in HTLV-1 pathogen-
esis as its expression appears to be critical for ATL de-
velopment and disease severity in HAM/TSP [27-29].
HBZ contains a bZIP motif, which enables it to hetero-
dimerize with cellular transcription factors in order to
regulate viral or cellular transcription. Thus, by interact-
ing with CREB, HBZ prevents the binding of CREB to
the CRE in the HTLV-1 LTR, resulting in the inhibition
of HTLV-1 gene transcription [30]. HBZ also interacts
with the transcription factor ATF3, thus preventing its
ability to enhance p53 transcriptional activity, and there-
fore the proliferation of ATL cells [31]. In addition, HBZ
is able to inhibit the classical NF-κB pathway by binding
p65 and therefore decreasing p65 DNA binding capacity,
a mechanism used by the virus to escape from the host
immune system [32]. Moreover, numerous studies have
also reported that HBZ interacts with AP-1 members of
the Jun subfamily such as c-Jun, JunB and JunD and
modulates their transcriptional activity [33,34]. The
interaction between HBZ and c-Jun as well as HBZ and
JunB results in repression of c-Jun and JunB activity
through degradation or sequestration into transcription-
ally inactive nuclear bodies [35-38]. However, by inter-
acting with JunD, HBZ can activate JunD-dependant
transcription of cellular genes including the human tel-
omerase reverse transcriptase [34,39].
The role of APH-2 in the pathogenesis of HTLV-2 in-
fection is less defined. To date, only one study reveals
that APH-2 does not promote lymphocytosis [40]. APH-
2 harbours a non-conventional bZIP motif as it displays
seven instead of six amino acids between the sixth and
the seventh leucine. Despite the lack of a classic bZIP
domain, APH-2 is still able to interact with CREB and
repress Tax2-mediated transcription activation of HTLV-
2 genes [25].
In the present report, we investigated the role of
HTLV-2 proteins APH-2 and Tax2B on AP-1 activity.
We demonstrated that APH-2 interacts with c-Jun and
JunB through its non-canonical bZIP domain andenhances their ability to activate AP-1 transcription. Sur-
prisingly, when APH-2 and Tax2B are co-expressed,
APH-2 binds Tax2B and acts as a repressor of Tax2B-
mediated activation of AP-1 transcription.
Taken together, our results reveal that both APH-2
and Tax2 act as transcription factors that subtly regulate
AP-1 transcription. These findings strongly suggest that
APH-2 and Tax2 are involved in the regulation of many
biological processes involving AP-1 and therefore indir-
ectly help the virus to replicate and/or counteract the
host’s immune system.Results
APH-2 stimulates the transcriptional activity of c-Jun,
JunB and JunD
In order to investigate the effect of APH-2 on basal AP-
1 transcription compared to HBZ, we performed lucifer-
ase assays using an AP-1 cis-reporter plasmid that
contains the luciferase reporter gene driven by a basic
promoter element plus seven repeats of AP-1 binding
sites. We transfected the luciferase reporter construct
together with increasing amounts of HBZ or APH-2 ex-
pression vectors into 293T cells (Figure 1A and 1B,
upper panels). The expression levels of the transfected
proteins were confirmed by Western blot (Figure 1A
and 1B, lower panels). Interestingly, while HBZ inhibits
AP-1-mediated transcription (Figure 1A, columns 2–4),
APH-2 stimulates basal AP-1 transcription in a dose de-
pendant manner (Figure 1B, columns 2–4).
Previous studies have shown that HBZ affects AP-1
transcription by modulating the transcriptional activity
of all members of the Jun subfamily. On the one hand,
HBZ represses transcription mediated by c-Jun and
JunB while it activates JunD-dependant transcription
[34,35,37,38]. To examine whether APH-2-mediated
activation of AP-1 transcription results in the stimula-
tion of Jun activity, we performed luciferase assays.
Cells were co-transfected with the AP-1-Luc reporter
construct, c-Jun, JunB or JunD as well as APH-2 ex-
pression vectors (Figure 1C, 1D and 1E, respectively,
upper panels). Western blot analysis demonstrated that
FLAG-APH-2 does not affect the levels of overex-
pressed c-Jun-Myc, FLAG-JunB and FLAG-JunD
(Figure 1C, 1D and 1E, respectively, lower panels). As
expected, in the absence of APH-2 expression, c-Jun
(Figure 1C, column 2), JunB (Figure 1D, column 2) and
JunD (Figure 1E, column 2) activate AP-1 transcription.
Interestingly, co-expression of APH-2 further enhances
c-Jun (Figure 1C, columns 3–5), JunB (Figure 1D,
columns 3–5) and JunD-mediated (Figure 1E, columns
3–5) transactivation.
These results collectively reveal that APH-2 is a co-
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Figure 1 APH-2 stimulates basal AP-1 transcription through c-Jun, JunB and JunD. 293T cells were transfected with the pAP-1 luciferase
construct and the indicated expression vectors. Luciferase and Renilla activities were measured 48 hours after transfection. The average of at least
three different experiments is shown. The expression levels of the transfected proteins were analysed by Western blot using the indicated
antibodies. (A) HBZ inhibits AP-1 transcription. (B) APH-2 activates AP-1-mediated transcription. (C, D and E) APH-2 enhances the stimulatory
effect of c-Jun, JunB and JunD, respectively, on an AP-1 responsive promoter.
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To further decipher the molecular mechanisms in the
property of APH-2 to activate Jun-mediated transcrip-
tion, we tested whether APH-2 interacts with c-Jun,
JunB and JunD in vivo. First, we co-transfected FLAG-
APH-2 and/or c-Jun-Myc expression vectors in 293T
cells as indicated, and the nuclear extracts were sub-
jected to co-immunoprecipitation (Figure 2A). FLAG
antibodies were able to detect FLAG-APH-2 in the nu-
clear extracts from cells overexpressing FLAG-APH-2
and c-Jun-Myc and immunoprecipitated with Myc anti-
bodies (Figure 2A, WB anti-FLAG, column 6). However,
no signal was obtained when FLAG-APH-2 or c-Jun-
Myc were overexpressed alone (Figure 2A, WB anti-
FLAG, columns 4 and 5). These results suggest that
APH-2 interacts with c-Jun in vivo. To test whether
APH-2 interacts with JunB and JunD, nuclear extracts
from 293T cells overexpressing APH-2-His and/or
FLAG-JunB (Figure 2B) or APH-2-His and/or FLAG-
JunD (Figure 2C) were immunoprecipitated with Hisantibodies. FLAG antibodies were able to detect FLAG-
JunB only in nuclear extracts overexpressing both APH-
2-His and FLAG-JunB confirming that APH-2 interacts
with JunB (Figure 2B, WB anti-FLAG, columns 4–6).
Surprisingly, FLAG-JunD was not detected either in the
immunoprecipitated nuclear extracts overexpressing
APH-2-His alone, FLAG-JunD alone or both APH-2-His
and FLAG-JunD indicating that APH-2 is unable to bind
JunD (Figure 2C, WB anti-FLAG, columns 4–6). Recip-
rocal co-immunoprecipitations confirmed the inter-
action of APH-2 with c-Jun and JunB but not JunD
(Additional file 1A, 1B and 1C, respectively).
To further characterize the interaction between APH-
2 and c-Jun/JunB, we tested whether APH-2 also associ-
ates with endogenous c-Jun and JunB. We, therefore,
co-immunoprecipitated endogenous c-Jun and JunB
from nuclear extracts of FLAG-APH-2 transfected cells.
As shown in Figure 2D (column 3) and Figure 2E
(column 3), FLAG-APH-2 was specifically detected in
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Figure 2 APH-2 interacts with c-Jun and JunB in vivo. 293T cells were transiently transfected with the indicated expression plasmids. Two
days after transfection, nuclear extracts were immunoprecipitated with the indicated antibodies (IP). The presence of proteins of interest in the
immunoprecipitates was visualized by Western blot using the indicated antibodies (WB). (A) APH-2 interacts with c-Jun. (B) APH-2 binds JunB.
(C) APH-2 does not interact with JunD. (D) APH-2 associates with endogenous c-Jun. (E) APH-2 associates with endogenous JunB.
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dimerizes with endogenous c-Jun and JunB.
The non-conventional bZIP domain of APH-2 is critical for
binding c-Jun and JunB and stimulating their
transcriptional activation
The leucine zipper motif of a conventional bZIP domain
is a protein-protein interaction domain consisting of
amphipathic α-helices that dimerize either as homodi-
mers or heterodimers to form a coiled-coil. Despite the
lack of a conventional bZIP domain, APH-2 is still able
to interact with CREB and repress Tax2-dependant acti-
vation of HTLV-2 gene transcription [25].
To assess whether the non-canonical bZIP domain
of APH-2 is required for its interaction with c-Jun
and JunB, we constructed a mutant of APH-2 that
lacks the leucine zipper motif and named it APH-
2ΔbZIP. Next, we performed co-immunoprecipitations
with nuclear extracts from 293T cells overexpressing
FLAG-APH-2ΔbZIP and/or c-Jun-Myc (Figure 3A) aswell as APH-2ΔbZIP-His and/or FLAG-JunB (Figure 3B).
Interestingly, neither c-Jun-Myc (Figure 3A, WB anti-
FLAG, column 6) nor FLAG-JunB (Figure 3B, WB anti-
FLAG, column 6) was able to co-immunoprecipitate
with FLAG-APH-2ΔbZIP and APH-2ΔbZIP-His res-
pectively, suggesting that APH-2ΔbZIP was no longer
able to physically bind c-Jun and JunB.
Finally, to test whether the absence of the non-
conventional bZIP domain could abolish the ability of
APH-2 to activate c-Jun and JunB-mediated transactiva-
tion, we carried out luciferase assays. 293T were trans-
fected with the AP-1-Luc reporter construct, c-Jun-Myc
or FLAG-JunB as well as APH-2ΔbZIP expression vec-
tors (Figure 3C and 3D, respectively, upper panels). The
expression levels of the transfected proteins were veri-
fied by Western blot (Figure 3C and 3D, lower panels).
As expected, APH-2ΔbZIP was unable to stimulate the
transcriptional activity of c-Jun and JunB (Figure 3C,
columns 3–5 and Figure 3D, columns 3–5, respectively).
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Figure 3 APH-2ΔbZIP does not interact with c-Jun and JunB and fails to stimulate their transcriptional activity. (A and B) APH-2ΔbZIP
does not bind to c-Jun or JunB, respectively. Nuclear extracts from 293T cells transfected with the indicated vectors were prepared 48 hours
post-transfection. Co-immunoprecipitations were then performed with Myc or His antibodies as indicated, followed by Western blotting with the
indicated antibodies (WB). (C and D) APH-2ΔbZIP does not stimulate the transcriptional activity of c-Jun and JunB. The pAP-1 luciferase reporter
construct was transiently co-transfected with the indicated expression vectors. Cells were lysed 48 hours post-transfection and processed for
luciferase assays and Western blot analysis. The luciferase values represent an average of at least three independent experiments.
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the non-conventional bZIP domain is required for
APH-2-mediated stimulation of JunD transactivation
(Additional file 2A and 2B).
Altogether, these results demonstrate that APH-2 binds
c-Jun and JunB via its non-conventional bZIP domain.
Moreover, this domain is crucial for APH-2 ability to
stimulate c-Jun and JunB-dependent AP-1 transcription.APH-2 interacts with Tax2B in vitro and in vivo and
represses the ability of Tax2B to stimulate AP-1
transcription
It has been previously reported that the HTLV-1 Tax
oncoprotein activates AP-1-mediated transcription [18].
To examine whether HTLV-2 Tax2B was also able to
affect AP-1 transcriptional activity, we carried out luci-
ferase assays using lysates from cells transfected with the
AP-1-Luc reporter construct together with increasing
amounts of Tax2B expression vector (Figure 4A, upper
panel). The amounts of Tax2B-His transfected were con-
firmed by Western blot (Figure 4A, lower panel). Our
results show that, similar to Tax1, Tax2B stimulates
AP-1 activity in a dose-dependent manner (Figure 4A,
columns 2–4).Taken together, our data show that both HTLV-2 pro-
teins Tax2B and APH-2 are individually able to activate
AP-1 transcription. In order to monitor AP-1 activity
when Tax2B and APH-2 are co-expressed, we conducted
luciferase assays on 293T cells co-transfected with the
AP1-Luc reporter construct and Tax2B-His and/or
FLAG-APH-2 expression vectors (Figure 4B, upper
panel). The expression levels of Tax2B-His and FLAG-
APH-2 were confirmed by Western blot analysis
(Figure 4B, lower panel). We speculated that Tax2B
and APH-2 effects on AP-1 activity are either additive
or synergistic. Unexpectedly, our data demonstrate
that APH-2 suppressed the activation of AP-1 tran-
scription by Tax2B, indicating that APH-2 acts as a re-
pressor of Tax2B-mediated transactivation (Figure 4B,
columns 3–5).
We next investigated whether Tax2B and APH-2
interact in vitro. To address this issue, we performed
GST pull-down assays with GST-APH-2 incubated
with purified Tax2B-His. As illustrated in Figure 4C,
GST-APH-2 binds Tax2B-His but not GST, indicating
that APH-2 interacts directly with Tax2B (Figure 4C,
columns 2 and 3).
To test whether APH-2 and Tax2B also interact
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Figure 4 APH-2 interacts with Tax2B and inhibits Tax2B-mediated activation of AP-1. (A and B) APH-2 neutralizes the stimulatory effect of
Tax2B on AP-1 activity. 293T cells were transiently co-transfected with the pAP-1 reporter vector as well as the indicated expression plasmids. Two
days after transfection, the cells were lysed and luciferase activities were measured. The graphs show an average from at least three independent
experiments. The proteins levels were analysed by Western blot using the indicated antibodies. (C) APH-2 interacts with Tax2B in vitro. Purified
Tax2B-His was incubated with GST or GST-APH-2 and a pull-down was carried out. The precipitate was analyzed using His antibodies (left panel).
The purified proteins were visualized by Coomassie blue staining (right panel). (D) APH-2 forms a complex with Tax2B in vivo. 293T cells were
transiently transfected with the indicated expression plasmids. Nuclear extracts were prepared two days after transfection and subjected to
immunoprecipitation with His antibodies. Proteins in the immunoprecipitates were analyzed by Western blot using the indicated antibodies (WB).
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immunoprecipitation assays with anti-His antibodies
(Figure 4D). Our data demonstrate that FLAG-APH-2
was detected in the immunoprecipitates from cells
co-transfected with FLAG-APH-2 and Tax2B-His
(Figure 4D, WB anti-FLAG, column 6) but not FLAG-
APH-2 or Tax2B-His alone (Figure 4D, WB anti-FLAG,
columns 4 and 5).
As previously described, Tax2B is mainly distributed in
the cytoplasm but can also be found in punctate nuclear
structures whereas APH-2 displays a predominant nu-
clear localization [25,41]. To test whether the expression
of Tax2B was able to alter APH-2 localization, we car-
ried out immunofluorescence experiments. Interestingly,Tax2B expression was able to relocate APH-2 to the nu-
clear periphery (Additional file 3A).
Altogether, these results suggest that Tax2B-His and
FLAG-APH-2 form a stable protein complex in vitro
and in vivo.
APH-2 and c-Jun/JunB interaction is independent of
Tax2B
In the present study, we identified two members of the
Jun family and the viral protein Tax2B as new APH-2
interaction partners. To investigate whether Tax2B and
c-Jun/JunB compete for APH-2 interaction when the
three protein partners are co-expressed, we performed
immunoprecipitation assays (Figure 5A and 5B). To this
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2, c-Jun-HA and increasing amounts of Tax2B-His were
immunoprecipitated with FLAG antibodies. The pres-
ence of c-Jun-HA in the immunoprecipitates was then
analyzed by Western blot using HA antibodies
(Figure 5A). Results show that the relative amounts of
c-Jun-HA detected in the immunoprecipitates were in-
dependent of Tax2B-His expression (Figure 5A, columns
2–4). Interestingly, Tax2B-His was also co-immunopreci-
pitated, suggesting that Tax2B is also part of the APH-2/
c-Jun complex (Figure 5A, columns 7–8).
As a control, we tested whether c-Jun was able to
affect Tax2B localization. The results obtained from our
immunofluorescence experiments show that c-Jun was
able to delocalize Tax2B from the cytoplasm to the nu-
cleus (Additional file 3B).
Similar co-immunoprecipitation experiments were per-
formed with nuclear extracts from cells transfected with
APH-2-His and FLAG-JunB either alone or together with
increasing amounts of Tax2B-His and immunoprecipitated
with FLAG antibodies (Figure 5B). As expected, Tax2B was
also part of the APH-2/JunB complex (Figure 5B, columns
3–4) but did not affect the interaction between APH-2 and
JunB (Figure 5B, columns 6–8). Conversely, additional co-
immunoprecipitations reveal that c-Jun and JunB did not
have an effect on the interaction between APH-2 and
Tax2B (Additional file 4A and 4B, respectively).
Overall our results strongly suggest that APH-2, Tax2B
and c-Jun/JunB can form a ternary complex. Similarly,
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Figure 5 Tax2B does not compete with c-Jun and JunB in their intera
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The interaction between APH-2 and Tax2B neither
involves the non-canonical bZIP domain nor the LXXLL
domain of APH-2
Thus far, we have demonstrated that there is no com-
petition between Tax2B and the Jun family members
for APH-2 binding (Figure 5). Interestingly, we also
reported that APH-2 interacts with c-Jun and JunB
through its non-canonical bZIP domain (Figure 3A
and 3B). We then speculated that the interaction be-
tween APH-2 and Tax2B might not involve the
non-canonical bZIP domain of APH-2. To confirm this
hypothesis, co-immunoprecipitations of the FLAG-
APH-2ΔbZIP mutant with Tax2B-His were determined
using His antibodies followed by Western blot with FLAG
antibodies to detect FLAG-APH-2ΔbZIP (Figure 6B). As
predicted, FLAG-APH-2ΔbZIP was present in the immu-
noprecipitate, confirming that APH-2 and Tax2B interact
in vivo but not through the non-conventional bZIP do-
main of APH-2 (Figure 6B, WB anti-FLAG, columns
4–6). Overall, these results reveal that c-Jun and JunB, but
not Tax2B, interact with APH-2 though its non-
conventional bZIP domain, which is consistent with our
data showing that c-Jun/JunB and Tax2B do not compete
for APH-2.
A recent study reported that the LXXLL motif of
APH-2 is important for CREB binding and repression of
Tax function on viral genes [42]. We therefore tested 
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ing and repression of Tax2B function on AP-1 transcrip-
tion. To this aim, we generated a mutant of APH-2 that
lacks the LXXLL motif and named it APH-2ΔLXXLL
(Figure 6A). Co-immunoprecipitations were carried out
with cellular extracts overexpressing FLAG-APH-
2ΔLXXLL and/or Tax2B-His and immunoprecipitated
with His antibodies (Figure 6C). Results revealed that
FLAG antibodies were able to detect FLAG-APH-
2ΔLXXLL in nuclear extracts overexpressing both pro-
teins, thus suggesting that Tax2B can still interact with
the APH-2ΔLXXLL mutant (Figure 6C, WB anti-FLAG,
column 6).
Furthermore, we carried out luciferase assays to test
the effects of these APH-2 mutants on Tax2B-mediated
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Figure 6 The non-conventional bZIP domain and the LXXLL motif of
representation of the APH-2 mutants. (B, C and E) Mapping of the interacti
with the indicated expression plasmids. Cellular extracts were prepared and
transfection. The presence of the proteins of interest in the immunoprecip
(WB). (D) The non-canonical bZIP domain of APH-2 is required to inhibit Ta
pAP-1 luciferase construct and the indicated expression vectors. Luciferase
average of at least three different experiments is shown. The expression lev
the indicated antibodies.were transfected with the AP-1-Luc reporter construct,
Tax2B and APH-2 full-length, ΔbZIP or ΔLXXLL. The
expression levels of Tax2B-His and FLAG-APH-2 con-
structs were confirmed by Western blot analysis
(Figure 6D, lower panel). Interestingly, even if the non-
canonical bZIP domain of APH-2 is not required for its
interaction with Tax2B, it appears crucial for Tax2B
function on AP-1 transcription as APH-2-mediated re-
pression of Tax2B function is completely inhibited when
this domain is deleted (Figure 6D, column 4). Unlike
ΔbZIP, the ΔLXXLL mutant was not able to abolish the
ability of APH-2 to repress Tax2B-mediated transactiva-
tion of AP-1 (Figure 6D, column 5).
Thus far, we have demonstrated that the interac-
tion between APH-2 and Tax2B does not involve the
two main domains of APH-2: the bZIP domainE Input 
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els of the transfected proteins were analysed by Western blot using
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order to further study the interaction between APH-
2 and Tax2B, we constructed a FLAG-tagged mutant
of APH-2 lacking the C-terminal part of the protein:
APH-2 (1–102) (Figure 6A). We then performed co-
immunoprecipitations with cellular extracts from 293T
cells overexpressing Tax2B and FLAG-APH-2 full-
length or N-terminal (1–102) in combination with
Tax2B-His (Figure 6E). Our data reveal that in contrast
with the full-length APH-2 (Figure 6E, WB anti-His,
column 4), the N-terminal part of APH-2 (1–102) is
unable to interact with Tax2B-His (Figure 6E, WB
anti-His, column 6). Overall, these results suggest that,
by default, APH-2 interacts with Tax2B through its
C-terminal part (137–177).APH-2 and Tax2B finely regulate the activity of the
collagenase promoter
Our report highlights the role of the viral proteins APH-
2 and Tax2B in the regulation of AP-1 activity using a
minimal promoter harbouring AP-1 binding sites as a
model. To examine the physiological relevance of these
findings, we investigated the effect of APH-2 and Tax2B
on the human collagenase promoter, which contains a
TRE [43,44]. We performed luciferase assays using a
construct containing the luciferase gene driven by the
human collagenase promoter (Figure 7). The reporter
plasmid along with Tax2B, c-Jun or JunB expression
plasmids were co-transfected in the absence or presence
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Figure 7 APH-2 and Tax2B modulate the activity of the collagenase p
pCollagenase-Luc and the indicated expression vectors. Luciferase and Ren
at least three different experiments is shown. The expression levels of Tax2
Western blot using the indicated antibodies. (A) APH-2 suppresses Tax2B-in
JunB-mediated transactivation of the collagenase promoter, respectively.luciferase assays (Figures 7A, 7B and 7C, respectively,
upper panels) and Western blot (Figures 7A, 7B and 7C,
respectively, lower panels). We observed that APH-2
and Tax2B overexpressed separately activated the col-
lagenase promoter as predicted by our study (Figure 7A,
columns 2 and 3). In the cells co-expressing both viral
proteins, APH-2 acted as an inhibitor by suppressing
Tax2B ability to induce collagenase transcription
(Figure 7A, column 4). The regulation of collagenase
gene transcription has been well documented and
both c-Jun and JunB were reported to activate the
collagenase promoter [45,46]. We were able to
confirm these findings in the context of our experi-
ments as c-Jun and JunB stimulated the activity of
the collagenase promoter by approximately 2 fold
(Figures 7B and 3C, columns 3). Co-expression of
APH-2 resulted in a stimulation of c-Jun and JunB-
mediated transactivation of about 14 and 9-fold acti-
vation relative to the basal level, respectively
(Figure 7B and 7C, columns 4).
These findings demonstrate that APH-2 acts synergis-
tically with c-Jun and JunB to activate transcription of
the collagenase promoter. Taken together our data sug-
gest that the collagenase promoter well illustrates how
APH-2 and Tax2B regulate AP-1 activity.Discussion
HTLV-1 and HTLV-2 differ both in their specific epide-
miologic and pathogenic properties. In contrast to
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duced collagenase transcription (B and C) APH-2 activates c-Jun and
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ciated with lymphocyte proliferation and high platelet
counts as well as rare cases of chronic neuromyelopathy
[7-9]. This suggests that HTLV-2 fails to promote a crit-
ical stage of leukemogenesis and neurologic disease
development.
The distinct clinical manifestations of HTLV-1 and
HTLV-2 can be attributed in part to distinct biological
functions of Tax1 and Tax2 [47]. For instance, the trans-
forming potential of Tax1 is higher than that of Tax2
mainly due to the fact that, unlike Tax1, Tax2 cannot ac-
tivate the non-canonical NF-κB pathway because of its
inability to interact with NF-κB2/p100 [48,49].
Although Tax plays a pivotal role in HTLV-associated
transformation of T-cells, the tax gene is frequently gen-
etically and epigenetically inactivated in ATL cells, sug-
gesting that Tax is not required for the maintenance of
the leukemic stage in ATL [50,51]. Recent studies
showed that transcription from the 3’ LTR of the HTLV
genomes governs the expression of antisense regulatory
proteins [24-26]. HBZ, the antisense protein encoded by
HTLV-1, is a bZIP factor that is consistently expressed
in ATL cells and plays a key role in the malignant proli-
feration in ATL [52]. HBZ interacts with numerous
cellular transcription factors of the bZIP family and
modulates their transcriptional activity. Notably, by
interacting with c-Jun, JunB and JunD, HBZ highly
influences AP-1 transcription [33,34].
In the current study, we reveal that the antisense pro-
tein of HTLV-2 (APH-2) also regulates AP-1 activity.
However, we postulate that HBZ and APH-2 display
opposite effects on AP-1 basal transcription. While HBZ
inhibits AP-1-mediated transcription, APH-2 acts as an
activator of AP-1 basal activity. Moreover, whereas HBZ
has been described as an inhibitor of c-Jun and JunB-
mediated transcription [33,38], we demonstrated that
APH-2 enhances the transcriptional activity of c-Jun and
JunB on AP-1 binding sites. As AP-1 controls numerous
biological processes critical in virus replication such as
oncogenic transformation, cell proliferation, differenti-
ation and apoptosis, we hypothesize that this divergence
in AP-1 transcription regulation might explain, in part,
the differences between HTLV-1 and HTLV-2 pathogen-
esis. A recent study already excluded the involvement of
APH-2 in lymphocyte proliferation [40], but further in-
vestigation is needed to establish the role of APH-2 in
other AP-1-associated biological functions.
We focused our studies on elucidating the molecular
mechanisms involved in the regulation of AP-1 activity
by APH-2 and demonstrated that APH-2 physically
interacted with c-Jun and JunB through its non-
conventional bZIP domain. HBZ harbours a bZIP do-
main that is involved in numerous biological functions
and especially in its interaction with c-Jun and JunB[33]. Interestingly, despite the lack of a consensus bZIP
domain, APH-2 was still able to interact with c-Jun and
JunB and therefore still share some similarities with
HBZ. Using a reporter assay, we established that this
non-canonical bZIP domain is critical for APH-2 to en-
hance c-Jun and JunB transcriptional activity on AP-1
transcription. These findings confirm that the physical
interaction between APH-2 and c-Jun/JunB is essential
for APH-2 to regulate c-Jun and JunB-mediated AP-1
transcription.
Interestingly, as previously described for HBZ [34],
APH-2 cooperates with JunD through its non-canonical
bZIP domain to stimulate the AP-1 activity. However,
our results show that APH-2 and JunD are not able
to form a stable complex in vivo. We postulate that
APH-2 and JunD might involve a different mechanism
of action than APH-2 and c-Jun/JunB to stimulate
AP-1 transcription. Further investigation is needed to
better understand how APH-2 indirectly stimulates
JunD transcriptional activity on AP-1 transcription.
The development of ATL in HTLV-1 infected patients
has been associated with the deregulation of cellular
gene transcription. Among all HTLV-1 proteins, Tax1 is
known to play a critical role in ATL development by dis-
rupting major cellular signal transduction pathways such
as NF-κB and AP-1 [18,47]. In the present study, we re-
veal that HTLV-2 Tax enhances AP-1 transcription.
However, when Tax2B and APH-2 are co-expressed,
they interact directly and APH-2 impairs the ability of
Tax2B to activate AP-1 transcription. These functional
effects could be explained by the fact that Tax2B can re-
locate APH-2 to the nuclear periphery, a mechanism
that could prevent APH-2 from activating AP-1 tran-
scription. Interestingly, similar functional effects have
been described on the HTLV-2 promoter [25], but fur-
ther experiments are required to investigate whether
Tax2B and APH-2 are using a common molecular mech-
anism to regulate HTLV-2 and AP-1 transcription.
Here, we report that APH-2, Tax2B and Jun can form
a ternary complex, as there is no competition between
Tax2B and c-Jun/JunB for APH-2 binding. Indeed, un-
like c-Jun/JunB, APH-2 and Tax2B, interaction does not
involve the non-canonical bZIP domain of APH-2. How-
ever, this domain, and consequently the interaction be-
tween APH-2 and c-Jun/JunB, is crucial to repress Tax
function on AP-1 transcription.
According to a recent study, the LXXLL motif of
APH-2 is involved in its interaction with CREB and in
the repression of Tax function on viral genes [42]. Sur-
prisingly, we demonstrated that this motif is not essen-
tial for APH-2 repressive function on Tax2B-mediated
AP-1 transcription and is not involved in Tax2B binding.
The human collagenase promoter is an extensively
studied AP-1 responsive promoter [43,44]. Here we used
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1 transcription regulation by the two HTLV-2 proteins
APH-2 and Tax2B. We established that, according to
our model, APH-2 stimulates c-Jun and JunB-mediated
transactivation. Moreover, APH-2 or Tax2B expressed
individually highly enhance AP-1 transcription whereas
co-expression of both viral proteins results in a suppres-
sion of Tax2B-mediated transactivation by APH-2. We
also speculate that the molecular mechanism by which
APH-2 and Tax2B regulate the collagenase transcription
could be common to numerous AP-1 target genes.
A recent study reported that both APH-2 and Tax2
mRNA expression are correlated with HTLV-2 proviral
loads (PVL). However, whereas APH-2 was expressed
in vivo in the majority of HTLV-2 carriers, Tax expres-
sion was not detected among HTLV-2 carriers with
low PVL [40]. With the intention of correlating this
study with our findings, we speculate that in HTLV-2
carriers with low PVL, only APH-2 is expressed and
consequently, AP-1 activity is stimulated. However, in
HTLV-2 carriers with high PVL, APH-2 and Tax2 are
co-expressed and AP-1 activity is down-regulated, sug-
gesting that APH-2 might balance the transactivation ac-
tivity of Tax2B on HTLV-2 and AP-1 transcription in
order to silence the virus and allow it to escape host im-
mune responses.
Conclusions
The present study is the first to demonstrate that
HTLV-2 deregulates AP-1 activity. Moreover, together
with a previous report [25], we confirm that APH-2 and
Tax2B act as viral transcription factors that subtly regu-
late HTLV-2 and AP-1 transcription to possibly help
the virus to replicate and counteract host immune
responses. Moreover, in accordance with previous stud-
ies [33,34,38], we report that APH-2 and HBZ display
similar repressive effects on AP-1-mediated transcrip-
tion in the presence of Tax but have opposite effects
in its absence. These findings highlight the fact that
APH-2 and HBZ have distinct biological properties
that may contribute to the differential pathogenic
potential of HTLV-1 and HTLV-2.
Methods
Cells and plasmids
The 293T cells (obtained from the ATCC) were cul-
tured under standard tissue culture conditions. The
pAP1-Luc and pRL-TK-Renilla plasmids are commer-
cially available at Stratagene and Promega, respectively.
The pCAGGS-Tax2B-His was previously described
[53]. The pFLAG-JunB and pFLAG-JunD were generous
gifts from Dr. Rong Li (Stowers Institute for Medical Re-
search, Kansas City, USA). The p-c-Jun-HA, pCollagenase-
Luc and p-c-Jun-Myc were kindly provided by Dr. AnnaMaria Musti (University of Würzburg, Germany), Dr. Sagar
Ghosh (University of Texas, San Antonio, USA) and Dr.
Kunitada Shimotohno (Chiba Institute of Technology,
Japan), respectively. The pGFP-APH-2 was obtained by
cloning the APH-2 cDNA into the pEGFP (Invitrogen)
using standard techniques. The pFLAG-APH-2 and
pFLAG-HBZ were generated by cloning the APH-2 or
HBZ cDNAs as a HindIII/EcoRI fragment obtained from
pcDNA-APH-2-Myc-His or pcDNA-HBZ-Myc-His (kindly
provided by Dr. Jean-Michel Mesnard, Université de Mont-
pellier, France) into pFLAG-CMV (Sigma-Aldrich). The
pFLAG-APH-2ΔbZIP and pAPH-2ΔbZIP-His mutants
were generated by site-directed mutagenesis (PhusionW
Site-Directed Mutagenesis kit, Thermo Scientific) using
pFLAG-APH-2 or pcDNA-APH-2-Myc-His as a template
and the following primers: 5’-TATACACTCCAACT
GCTGATGCCTTTC-3’ and 5’-GAGGAACTATTTGAG
GCAATTATTCAG-3’. The pFLAG-APH-2ΔLXXLL and
pFLAG-APH-2 (1–102) mutants were also constructed by
site-directed mutagenesis (PhusionW Site-Directed Muta-
genesis kit, Thermo Scientific) using pFLAG-APH-2 as a
template and the primers: 5’-TAAGAATTCATCGATAG
ATCTGATATCGGT-3’ and 5’- CTTCTGCAGCAAAT
CCCCATGGTT-3’ for pFLAG-APH-2ΔLXXLL and 5’-
TAAGAATTCATCGATAGATCTGATATCGGT-3’ and
5’- TATACACTCCAACTGCTGATGCCTTTC-3’ for
pFLAG-APH-2 (1–102). To obtain the GST-APH-2 con-
struct, we generated an APH-2 PCR product using the
pcDNA-APH-2-Myc-His as a template. The APH-2 PCR
product was then digested with BamHI/EcoRI and cloned
into the pGEX-2 T (GE Healthcare).
Luciferase assays
293T cells were transiently transfected with the pAP1-
Luc or pcollagenase reporter plasmids, different com-
binations of expression vectors and the pRL-TK-
Renilla vector as an internal control using Lipofecta-
mine™ 2000 (Invitrogen). DNA amounts were nor-
malized across samples using the respective empty
vectors. Cells were harvested 48 hours post-
transfection and processed for luciferase assays (Dual
LuciferaseW Reporter Assay System, Promega) or
Western blot.
Co-immunoprecipitations
293T cells were transiently transfected with different
combinations of expression vectors using Lipofecta-
mine™ 2000 (Invitrogen). DNA amounts were normal-
ized across samples using the respective empty vectors.
Protein extracts were prepared 48 hours after
transfection (NE-PERW Nuclear and Cytoplasmic Extrac-
tion Reagents, Thermo Scientific) and 400ug of
protein extracts were immunoprecipitated with 5ug of
anti-FLAGW M2 (Sigma-Aldrich, F3165), anti-Myc
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c-Jun (Abcam ab31419), anti-JunB (Abcam ab31421) or
rabbit IgG (Millipore) overnight at 4°C. Protein A/G
PLUS-Agarose beads (Santa Cruz Biotechnology) were
then added to the samples and incubated for 2 hours
at 4°C. Beads were washed 3 times with IPLS buffer
(50 mM Tris–HCl pH7.5, 120 mM NaCl, 0.5 mM
EDTA, 0.5% NP-40), 3 times with IPHS buffer (50 mM
Tris–HCl pH7.5, 400 mM NaCl, 0.5 mM EDTA, 0.5%
NP-40) and twice with IPLS buffer. Samples were then
subjected to Western blot.
Western blotting
Cell lysates were subjected to SDS-PAGE and analyzed
by Western blot using standard procedures. Membranes
were probed using the SNAP i.d. system (Millipore).
The antibodies used for Western blot are as follows:
anti-FLAGW M2 (Sigma-Aldrich, F3165), anti-α-tubulin
(Abcam, Ab7291), anti-Myc (Invitrogen, R950), anti-
6xHis (Clontech, 631212) and anti-HA (Invitrogen,
32–6700).
GST pull-down
Purified GST or GST-APH-2 fusion proteins were
immobilized on Glutathione Sepharose™ 4 Fast Flow
beads (GE Healthcare) and incubated with purified
Tax2B-His overnight at 4°C. After extensive washing
with GST Wash Buffer (0.5% TritonW X-100 in PBS sup-
plemented with protease inhibitors), bound proteins
were eluted using GST Elution Buffer (50 mM Tris–HCl
pH8.0, 10 mM reduced glutathione) and separated by
Western blot. Tax2B-His was detected with anti-6xHis
antibodies (Clontech, 631212).
Immunofluorescence
COS-7 cells were plated onto chamber slides and co-
transfected with the indicated expression vectors using
FuGENEW HD (Promega). One day post-transfection,
cells were washed with PBS, fixed with 4% paraformalde-
hyde for 15 minutes at room temperature, permeabilized
with 0.2% Tween/PBS for 10 minutes at room
temperature and incubated with a blocking reagent
(TSA kit, Molecular Probes) for 1 hour at room
temperature. Tax2B was detected with an anti-Tax2B
antibody (Fusion Antibodies) followed by anti-mouse
IgG-HRP and Alexa FluorW 594 tyramide staining
(Molecular Probes). c-Jun-Myc was detected using an
anti-Myc-HRP antibody (Invitrogen, R951) followed
by Alexa FluorW 488 tyramide staining (Molecular
Probes). DAPI (Sigma-Aldrich) was used to stain the
nuclei. Slides were mounted using the ProLongW Gold
Antifade reagent (Invitrogen). Images were acquired
with a Zeiss Axio Imager microscope.Additional files
Additional file 1: APH-2 associates with c-Jun and JunB but not
JunD. 293T cells were transiently transfected with the indicated
expression plasmids. Two days after transfection, nuclear extracts were
immunoprecipitated with the indicated antibodies (IP). The presence of
proteins of interest in the immunoprecipitates was visualized by Western
blot using the indicated antibodies (WB). (A) APH-2 interacts with c-Jun.
(B) APH-2 binds JunB. (C) APH-2 does not interact with JunD.
Additional file 2: APH-2ΔbZIP fails to stimulate JunD-mediated
transcriptional activity. (A) APH-2ΔbZIP does not bind to JunD. Nuclear
extracts from 293T cells transfected with the indicated vectors were
prepared 48 hours post-transfection. Co-immunoprecipitations were then
performed with His antibodies, followed by Western blotting with the
indicated antibodies (WB). (B) APH-2ΔbZIP does not stimulate the
transcriptional activity of JunD. The pAP-1 luciferase reporter construct
was transiently co-transfected with the indicated expression vectors. Cells
were lysed 48 hours post-transfection and processed for luciferase assays
and Western blot analysis. The luciferase values represent an average of
at least three independent experiments.
Additional file 3: Subcellular localization of APH-2 and c-Jun in the
presence of Tax2B. COS-7 cells were transfected with the indicated
plasmids. Cells were fixed and permealized 24 hours post-transfection.
The proteins of interest were immunodetected and stained as indicated.
Nuclei were stained with DAPI. Immunofluorescence images were
obtained with a Zeiss Axio Imager microscope. Representative images of
the entire cell population are shown. (A) Tax2B relocates APH-2 to the
nuclear periphery. (B) c-Jun relocates Tax2B in the cell nuclei.
Additional file 4: c-Jun and JunB do not compete with Tax2B in its
interaction with APH-2. Competition-binding assays were performed
with nuclear extracts from 293 T cells overexpressing the indicated
tagged-proteins. Co-immunoprecipitations were carried out using the
indicated antibodies and the co-immunoprecipitated proteins were
detected by Western blot using the indicated antibodies (WB). (A and B)
c-Jun and JunB do not affect the interaction between APH-2 and Tax2B.
Additional file 5: APH-2 and c-Jun/JunB interaction is independent
of Tax2A. (A and B) Tax2A does not affect the interaction between
APH-2 and c-Jun/JunB. Competition-binding assays were performed
with nuclear extracts from 293 T cells overexpressing the indicated
tagged-proteins. Co-immunoprecipitations were carried out using FLAG
antibodies and the co-immunoprecipitated proteins were detected by
Western blot using the indicated antibodies.
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